Trial intelligence / Profile preview

Intrathecal Dexmedetomidine With Bupivacaine in Knee Orthopedic Surgery

NCT07522736Recruiting

Sponsor
Cairo University
Start
Mar 2025
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Time to request rescue analgesia at 24 hours. Started Mar 2025; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07522736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07522736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call